1Sakorafas GH,Blanchard K,Sarr MG,et al.Paget's disease of the breast:a clinical perspective.[J].Langenbecks Arch Surg,2001,386(6);445-450.
2Piekarski J,Jeziorski A,Baklinska W,et al.Patients with Paget disease of nipple and with palpable mass in breast have unfavorable prognosis[J].J Exp Clin Cancer Res,2004,23(1):33-37.
3Sheen-Chen SM,Chen HS,Chen WJ,et al.Paget disease of the breast-an easily overlooked disease[J]?Surg Oncol,2001,76(4):261-265.
4Kollmorgen DR,Varanasi JS,Edge SB,et al.Paget's disease of the breast:a 33-year experience[J].J Am Coll Surg,1998,187(2):171-177.
5Salvadori B,Fariselli G,SaccozziR.Analysis of 100 cases of Paget's disease of breast[J].Tumori,1976,62(2):529-535.
6Fu W,Loboekio A,Silberberg BK,et al.Molecular markes in Paget disease of the breast.[J].J Surg Oncol,2001,77(3):171-178.
8Brummer O,Stegner HE,Bohmer G,et al.HER-2/neu expression in Paget disease of the vulva and the female breast[J].Gynecol Oncol,2004,95(2):336-340.
二级参考文献11
1Dorssers LC,Van der Flier S,Brinkman A,et al.Tamoxifen resistance in breast cancer:elucidating mechanisms[J].Drugs,2001,61(12):1721-1733.
2Schindl M,Schoppmann SF,Samonigg H,et al.Overexpression of hypoxia inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer[J].Clin Cancer Res,2002,8:1831-1837.
3Ding SL,Shen LF,Yu JC,et al.Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma[J].J Biomed Sci,2004,11(6):911-919.
4Jensen EV,Cheng G,Palmieri C,et al.Estrogen receptors and proliferation markers in primary and recurrent breast cancer[J].Proc Natl Acad Sci USA,2001,98(26):15197-15202.
5Houston SJ,Plunkett TA,Barnes DM,et al.Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer[J].Br J Cancer,1999,78(7-8):1220-1226.
6Gutierrez MC,Detre S,Johnston S,et al.Molecular changes in taqmoxifen-resistant breast cancer:relationship between estrogen receptor,HER-2,and P38 mitogen-activated protein kinase[J].J Clin Oncol,2005,23(11):2469-2476.
7Gruber G,Greiner RH,Hlushchuk R,et al.Hypoxia-inducible factor 1 alpha in high-risk breast cancer:an independent prognostic parameter[J]?Breast Cancer Res,2004,6(3):R191-198.
8Witters L,Engle L,Lipton A.Restoration of estrogen responsiveness by blocking the HER-2/neu pathway[J].Oncol Rep,2002,9(6):1163-1166.
9Kurebayashi J,Otsuki T,Moriya T,et al.Hypoxia reduces hormone responsiveness of human breast cancer cells[J].Jpn J Cancer Res,2001,92:1093-1101.
10Cho J,Kim D,Lee S,et al.Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-lalpha in MCF-7 human breast cancer cells[J].Mol Endocrinol,2005,19(5):1191-1199.
3Kay S. Paget's disease of the nipple[J].SGO, 1966,123(5):1010.
4Freund H, Maydovnik M, Laufer N, et al. Paget's disease of the breast[J].Surg Oncology, 1977,9 ( 1 ) :93-98.
5Ikeeda DM, Helvie MA, Frank TS, et al. Paget disease of the nipple: radiol-Ogic-pathologic correlation[J]. Radiology, 1993,189( 1 ):89-94.
6Chen C Y, Sun L M, Anderson B O, et al. Paget disease of the breast: changing patterns of incidence, clinical presentation, and treat - ment in the U. S. [ J ]. Cancer, 2012,107 (7) : 1 448 - 1 458.
7Meyer - Gonzalez T, Alcaide - Martin A, Contreras - Steyls M, et al. Pigmented mammary Paget disease mimicking cutane- ous melanoma [J]. Int J Dermatol,2012,49( 1 ) :59 -61.
